SG Americas Securities LLC bought a new position in shares of 908 Devices Inc. (NASDAQ:MASS – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 11,861 shares of the company’s stock, valued at approximately $133,000.
Several other hedge funds have also recently modified their holdings of the stock. American Century Companies Inc. acquired a new stake in 908 Devices in the 3rd quarter worth about $87,000. GSA Capital Partners LLP acquired a new position in 908 Devices during the third quarter worth about $112,000. AQR Capital Management LLC purchased a new position in 908 Devices in the 3rd quarter worth approximately $116,000. AWM Investment Company Inc. purchased a new stake in shares of 908 Devices in the third quarter valued at approximately $3,740,000. Finally, Northern Trust Corp boosted its stake in 908 Devices by 4.9% during the third quarter. Northern Trust Corp now owns 184,944 shares of the company’s stock worth $1,232,000 after buying an additional 8,582 shares during the last quarter. Institutional investors and hedge funds own 88.06% of the company’s stock.
908 Devices Trading Down 3.5 %
Shares of MASS stock opened at $5.59 on Thursday. The company’s 50-day moving average price is $6.89 and its 200-day moving average price is $7.10. 908 Devices Inc. has a twelve month low of $4.85 and a twelve month high of $12.51. The stock has a market cap of $183.97 million, a price-to-earnings ratio of -4.95 and a beta of 0.93.
Insider Buying and Selling at 908 Devices
In related news, CFO Joseph H. Iv Griffith sold 5,698 shares of the firm’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $7.00, for a total transaction of $39,886.00. Following the completion of the sale, the chief financial officer now directly owns 89,711 shares of the company’s stock, valued at approximately $627,977. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other 908 Devices news, CFO Joseph H. Iv Griffith sold 5,698 shares of the stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $7.00, for a total transaction of $39,886.00. Following the completion of the transaction, the chief financial officer now owns 89,711 shares of the company’s stock, valued at $627,977. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Kevin J. Knopp sold 9,071 shares of 908 Devices stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $7.00, for a total transaction of $63,497.00. Following the sale, the chief executive officer now owns 411,981 shares of the company’s stock, valued at $2,883,867. The disclosure for this sale can be found here. Insiders have sold 20,001 shares of company stock worth $139,955 over the last quarter. 27.80% of the stock is currently owned by company insiders.
About 908 Devices
908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.
Featured Stories
- Five stocks we like better than 908 Devices
- Stock Market Upgrades: What Are They?
- United Airlines Soars on Earnings Beat
- How is Compound Interest Calculated?
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Stock Analyst Ratings and Canadian Analyst Ratings
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for 908 Devices Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 908 Devices and related companies with MarketBeat.com's FREE daily email newsletter.